Top Markets
#1 QuantixAI QuantixAI +36.56%
#2 MowCat MowCat +29.59%
#3 UnifAI Network UnifAI Network +27.58%
#4 GEKKO GEKKO +27.26%
#5 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +24.76%
#6 Derive Derive +23.51%
#7 Prom Prom +23.08%
#8 MarsCoin MarsCoin +20.61%
#9 Kinesis Silver Kinesis Silver +19.70%
#10 Versatize Coin Versatize Coin +16.65%
Coin of the day
QuantixAI QuantixAI
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Captor Therapeutics Spolka Akcyjna Captor Therapeutics Spolka Akcyjna

Captor Therapeutics Spolka Akcyjna

CTX
Classifica tra le azioni #20489
Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the... Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. Its products in various stages of development include CT-03, which has completed the Phase 1 clinical trials for the treatment of non-small cell lung cancer, triple-negative breast cancer, as well as cancers of the blood, lymphatic system, and bone marrow; and CT-01, which also completed the Phase 1 clinical trials for the treatment of hepatocellular carcinoma, through degradation of oncofetal transcription factor. The company was incorporated in 2015 and is headquartered in Wroclaw, Poland.
Prezzo delle azioni
$20.33
Capitalizzazione di mercato
$128.73M
Variazione (1 giorno)
-1.10%
Variazione (1 anno)
80.41%
Paese
PL
Scambia Captor Therapeutics Spolka Akcyjna (CTX)

Categoria

Healthcare
Utile per Captor Therapeutics Spolka Akcyjna (CTX)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Captor Therapeutics Spolka Akcyjna, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Captor Therapeutics Spolka Akcyjna dal 2026 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
Non abbastanza dati per le date fornite.
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH